Leadership Overview
Eris Lifesciences has 4 executives leading key functions including operations, marketing, and strategy.
Driven by a commitment to patient well-being, Eris Lifesciences focuses on advancing chronic lifestyle disease management through innovation and rigorous clinical studies, solidifying its market leadership in India.
Driven by a commitment to patient well-being, Eris Lifesciences focuses on advancing chronic lifestyle disease management through innovation and rigorous clinical studies, solidifying its market leadership in India.
Leadership Roles at Eris Lifesciences
V. Krishnakumar - Executive Director & Chief Operating Officer
V. Krishnakumar, the Executive Director & Chief Operating Officer at Eris Lifesciences, directs all operational facets of the company's branded formulations business. Overseeing the intricate supply chain and manufacturing processes, Krishnakumar ensures the efficient delivery of critical pharmaceutical products across India. This leadership role involves optimizing production schedules and maintaining stringent quality control standards, directly supporting Eris Lifesciences' mission to improve patient care. By driving operational excellence, V. Krishnakumar enhances the company's capacity to serve healthcare professionals and patients with a diverse range of products in cardio-metabolic, anti-diabetes, dermatology, and gynecology sectors. The focus remains on streamlining internal processes to facilitate market expansion and reinforce Eris's position in chronic lifestyle-related disease management.
R. Murari - President
R. Murari, the President at Eris Lifesciences, provides overarching strategic direction and executive leadership for the organization. Murari guides the company's expansion efforts and fosters a culture of innovation, crucial for Eris Lifesciences' focus on branded formulations and chronic lifestyle-related diseases. This position involves high-level decision-making that shapes the company's market approach and product development pipeline, particularly within the cardio-metabolic, anti-diabetes, dermatology, and gynecology sectors. By overseeing key strategic partnerships and corporate development, R. Murari ensures Eris Lifesciences remains at the forefront of improving patient care in India. The leadership provided by Murari is instrumental in driving the company's growth and reinforcing its commitment to pioneering studies that enhance health outcomes for patients nationwide.
Gagan Atreja - President, Operations
Gagan Atreja, the President, Operations at Eris Lifesciences, manages and enhances the company's operational infrastructure and efficiency. Atreja focuses on optimizing the manufacturing and distribution networks to ensure the consistent availability of Eris Lifesciences' diverse product range across India. This leadership function is critical for supporting the company's specialization in branded formulations, particularly in therapeutic areas like cardio-metabolic health and anti-diabetes. By driving process improvements and implementing best practices, Gagan Atreja directly contributes to Eris's ability to serve healthcare professionals and patients effectively. The operational oversight by Atreja ensures that Eris Lifesciences can continue its mission of improving patient care through innovative initiatives and pioneering studies in chronic lifestyle-related diseases.
Manoj Mallick - Markrting
Manoj Mallick, the Markrting at Eris Lifesciences, spearheads the strategic marketing initiatives for the company's extensive product portfolio. Mallick drives brand awareness and market penetration for Eris's specialized offerings in cardio-metabolic health, anti-diabetes, dermatology, and gynecology. This role involves developing and executing targeted campaigns to engage healthcare professionals and patients across India, emphasizing the company's commitment to improving health outcomes. By analyzing market trends and consumer needs, Manoj Mallick ensures that Eris Lifesciences' innovative solutions reach those who benefit most from chronic lifestyle disease management. The marketing strategies implemented by Mallick directly contribute to strengthening Eris's market presence and reinforcing its reputation for pioneering studies and patient-centric approaches.
Explore Leadership Teams in Manufacturing
Cipla Limited is a global pharmaceutical company based in Mumbai, India, with operations in India, the United States, South Africa, and other international markets. Through its Pharmaceuticals and New Ventures segments, the company develops, manufactures, markets, and distributes a broad range of generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and finished formulations. Its products address multiple therapeutic areas, including cardiovascular disease, pulmonary and kidney conditions, neurological and psychiatric disorders, HIV/AIDS, respiratory and asthma care, oncology, diabetes and metabolic disorders, infectious diseases, critical care, women’s health, ophthalmology, and child health. In addition to its core pharmaceutical portfolio, Cipla is active in consumer healthcare, biosimilars, and specialty medicine businesses. Founded in 1935, Cipla has grown into a major global healthcare player.
Company Leadership GJ
LV
LB
Founded in 2003, Phibro Animal Health Corporation is a global manufacturer and marketer of animal health pharmaceuticals, animal nutrition, and performance products. The company is headquartered in Teaneck, New Jersey.
Company Leadership
SL
RF
MG
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
Company Leadership
RG
RL
Zai Lab functions as a bio-pharmaceutical and drug discovery company with a focus in oncology and autoimmune diseases. The company was established in 2014 and is headquartered out of Shanghai, China.
Company Leadership DL
HR
XW
Frequently Asked Questions Regarding Eris Lifesciences Top Executives and Leadership Team
